Holen Sie sich die Stockscreener-App
580.57
2.22%
-13.18
Handel nachbörslich:
580.57
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt TMO?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$593.75
Offen:
$585.59
24-Stunden-Volumen:
1.96M
Relative Volume:
1.05
Marktkapitalisierung:
$222.07B
Einnahmen:
$42.88B
Nettoeinkommen (Verlust:
$6.34B
KGV:
35.12
EPS:
16.53
Netto-Cashflow:
$7.27B
1W Leistung:
-0.64%
1M Leistung:
+9.13%
6M Leistung:
-5.70%
1J Leistung:
+5.21%
1-Tages-Spanne:
$576.85
$591.86
1-Wochen-Bereich:
$566.70
$610.97
52-Wochen-Spanne:
$493.30
$627.88
Thermo Fisher Scientific Inc Stock (TMO) Company Profile
Firmenname
Thermo Fisher Scientific Inc
Sektor
Branche
Telefon
(781) 622-1000
Adresse
168 THIRD AVENUE, WALTHAM, MA
Vergleichen Sie TMO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TMO
Thermo Fisher Scientific Inc
|
580.57 | 222.07B | 42.88B | 6.34B | 7.27B | 16.53 |
|
DHR
Danaher Corp
|
215.01 | 154.61B | 23.88B | 3.90B | 5.30B | 5.28 |
|
A
Agilent Technologies Inc
|
147.04 | 41.95B | 6.51B | 1.29B | 1.37B | 4.42 |
|
IDXX
Idexx Laboratories Inc
|
465.03 | 38.08B | 3.84B | 866.24M | 792.60M | 10.37 |
|
IQV
Iqvia Holdings Inc
|
200.04 | 36.31B | 15.32B | 1.41B | 1.96B | 7.62 |
Thermo Fisher Scientific Inc Stock (TMO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-01-10 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2024-12-23 | Eingeleitet | Scotiabank | Sector Perform |
| 2024-10-14 | Eingeleitet | Redburn Atlantic | Buy |
| 2024-10-01 | Eingeleitet | Stephens | Overweight |
| 2024-08-28 | Eingeleitet | Wells Fargo | Overweight |
| 2024-06-03 | Fortgesetzt | Jefferies | Buy |
| 2024-03-18 | Fortgesetzt | Citigroup | Neutral |
| 2024-01-24 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2024-01-08 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2023-12-18 | Eingeleitet | HSBC Securities | Buy |
| 2023-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2023-10-26 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-10-25 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2023-09-28 | Eingeleitet | Bernstein | Outperform |
| 2023-09-06 | Fortgesetzt | Citigroup | Buy |
| 2023-07-19 | Eingeleitet | Raymond James | Outperform |
| 2023-07-19 | Bestätigt | Robert W. Baird | Outperform |
| 2023-07-13 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2023-04-04 | Bestätigt | Barclays | Overweight |
| 2022-12-14 | Eingeleitet | Deutsche Bank | Buy |
| 2022-12-07 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-10-27 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2022-08-25 | Eingeleitet | Credit Suisse | Neutral |
| 2022-04-25 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2022-01-26 | Fortgesetzt | Barclays | Overweight |
| 2021-10-20 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-07-16 | Eingeleitet | The Benchmark Company | Buy |
| 2021-03-18 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-03 | Eingeleitet | Barclays | Overweight |
| 2021-01-08 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2020-12-16 | Herabstufung | Citigroup | Buy → Neutral |
| 2020-12-02 | Eingeleitet | Goldman | Buy |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2020-09-30 | Eingeleitet | Atlantic Equities | Overweight |
| 2020-09-14 | Eingeleitet | Morgan Stanley | Overweight |
| 2020-08-20 | Fortgesetzt | JP Morgan | Overweight |
| 2020-07-15 | Hochstufung | Cleveland Research | Neutral → Buy |
| 2020-07-07 | Bestätigt | Needham | Buy |
| 2020-04-23 | Bestätigt | Needham | Buy |
| 2020-01-31 | Bestätigt | Needham | Buy |
| 2020-01-22 | Eingeleitet | Credit Suisse | Neutral |
| 2020-01-08 | Eingeleitet | Wells Fargo | Equal Weight |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2019-11-15 | Eingeleitet | Stifel | Buy |
| 2019-07-25 | Bestätigt | Needham | Buy |
| 2019-07-16 | Herabstufung | Needham | Strong Buy → Buy |
| 2019-05-30 | Eingeleitet | Wolfe Research | Outperform |
| 2019-05-23 | Bestätigt | Needham | Strong Buy |
| 2019-04-22 | Bestätigt | Needham | Strong Buy |
| 2019-04-16 | Bestätigt | BofA/Merrill | Buy |
Alle ansehen
Thermo Fisher Scientific Inc Aktie (TMO) Neueste Nachrichten
Fungal Keratitis Treatment Market Growth By 2031 | Harrow Inc., - openPR
Thermo Fisher continues viral vector withdrawal; lays off 300 employees - Yahoo Finance
Beach Investment Counsel Inc. PA Has $2.78 Million Position in Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
Thermo Fisher Scientific Inc. (NYSE:TMO) Shares Purchased by Compass Capital Management Inc. - MarketBeat
Renewable Energy Milestone: Thermo Fisher's Strategic Solar Deal Transforms European Operations - StockTitan
Calamos Wealth Management LLC Sells 18,727 Shares of Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
abrdn plc Sells 9,482 Shares of Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
Thermo Fisher Scientific Inc: An Exploration into Its Intrinsic Value - Yahoo Finance
Resonant Capital Advisors LLC Has $733,000 Position in Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
Stock Yards Bank & Trust Co. Reduces Holdings in Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
Sodium Chlorate Market to surpass USD 7.2 Billion by 2034, Says Global Market Insights inc. - GlobeNewswire Inc.
Freeze-drying Equipment Market Set to Witness Significant Growth by 2025-2032: Telstar, Thermo Fisher - EIN News
Thermo Fisher Scientific’s SWOT analysis: stock outlook amid market shifts By Investing.com - Investing.com Nigeria
Thermo Fisher Scientific's SWOT analysis: stock outlook amid market shifts By Investing.com - Investing.com Australia
Thermo Fisher cuts 300 Massachusetts jobs - NBC Boston
Thermo Fisher’s latest job cuts impact hundreds of Massachusetts employees - The Business Journals
Redburn Atlantic Adjusts Price Target on Thermo Fisher Scientific to $655 From $645, Keeps Buy Rating - Marketscreener.com
Stephens Adjusts Price Target on Thermo Fisher Scientific to $660 From $640, Keeps Overweight Rating - Marketscreener.com
Thermo Fisher's layoff spree continues with 300 dismissals in Massachusetts - NewsBreak
Scotiabank Forecasts Strong Price Appreciation for Thermo Fisher Scientific (NYSE:TMO) Stock - MarketBeat
Thermo Fisher Scientific's SWOT analysis: stock outlook amid market shifts - Investing.com
$1000 Invested In This Stock 10 Years Ago Would Be Worth This Much Today - Benzinga
Raymond James Reaffirms Outperform Rating for Thermo Fisher Scientific (NYSE:TMO) - MarketBeat
Rheos Capital Works Inc. Purchases 8,300 Shares of Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
Thermo Fisher Scientific Inc. (NYSE:TMO) Shares Purchased by JB Capital LLC - MarketBeat
Chicago Capital LLC Has $20.59 Million Stake in Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
Abner Herrman & Brock LLC Has $9.13 Million Stock Position in Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
HHM Wealth Advisors LLC Has $302,000 Stock Position in Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
Thermo Fisher Scientific (NYSE:TMO) Posts Quarterly Earnings Results, Beats Expectations By $0.16 EPS - MarketBeat
Thermo Fisher Scientific Reports Strong Financial Results for Fourth Quarter and Full Year 2024WALTHAM, Mass. (January 30, 2025) – Thermo Fisher Scientific Inc. (NYSE: TMO) announced its financial results for the fourth quarter and full year ended De - Defense World
Leerink Partnrs Issues Negative Estimate for TMO Earnings - Defense World
Thermo Fisher Scientific (NYSE:TMO) Price Target Raised to $678.00 - Defense World
Thermo Fisher Scientific (NYSE:TMO) Announces Quarterly Earnings Results - MarketBeat
Unlocking the Future: Why Investing in Thermo Fisher Could Be Your Best Move Yet! - Jomfruland.net
Is Thermo Fisher Scientific (TMO) the Best Cancer Stock to Buy According to Hedge Funds? - Insider Monkey
China Universal Asset Management Co. Ltd. Increases Stock Position in Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
SeaBridge Investment Advisors LLC Lowers Holdings in Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
Thermo Fisher Scientific Inc. (NYSE:TMO) Stock Holdings Increased by Independence Bank of Kentucky - MarketBeat
Marietta Wealth Management LLC Increases Holdings in Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
Destiny Wealth Partners LLC Takes Position in Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
633 Shares in Thermo Fisher Scientific Inc. (NYSE:TMO) Bought by Avantra Family Wealth Inc. - MarketBeat
Osborne Partners Capital Management LLC Acquires 697 Shares of Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
Tritonpoint Wealth LLC Grows Position in Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
Clear Creek Financial Management LLC Grows Position in Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
Heck Capital Advisors LLC Purchases New Position in Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
Citigroup Boosts Thermo Fisher Scientific (NYSE:TMO) Price Target to $650.00 - Defense World
Sumitomo Life Insurance Co. Has $10.11 Million Holdings in Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
Robust Analytical Instruments Segment Likely to Aid TMO's Q4 Earnings - MSN
Thermo Fisher Scientific beats Q4 estimates, shares rise - MSN
R Squared Ltd Acquires New Position in Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
Citigroup Increases Thermo Fisher Scientific (NYSE:TMO) Price Target to $650.00 - MarketBeat
Finanzdaten der Thermo Fisher Scientific Inc-Aktie (TMO)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.35%
1.07%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):